Physician profile
Michael H Simpson
NPI 1194895680
$3,526.97
in general payments reported to CMS, 2019-2025
30 companies · $460 in 2025
The $460 reported for 2025 was more than what a typical Obesity Medicine (Family Medicine) provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $521 · 2020: $249 · 2021: $561 · 2022: $503 · 2023: $505 · 2024: $727 · 2025: $460.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,686 · Education: $7.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,685.87 |
| Education | $7.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Currax Pharmaceuticals LLC | $748.93 | 2020-2025 | Contrave |
| Novo Nordisk INC | $425.76 | 2019-2025 | Wegovy |
| Endo Pharmaceuticals INC. | $346.54 | 2019-2024 | Nascobal |
| Lilly USA, LLC | $309.31 | 2024-2025 | Zepbound, Jardiance, Mounjaro |
| Takeda Pharmaceuticals U.S.A., INC. | $254.26 | 2019-2024 | Gattex |
| Ironwood Pharmaceuticals, INC | $232.08 | 2019-2022 | |
| W. L. Gore & Associates, INC. | $187.89 | 2021-2025 | Gore Seamguard Bioabsorbable Staple Line Reinforce, Gore Synecor Biomaterial |
| Boston Scientific Corporation | $147.92 | 2021-2024 | Watchman Access System |
| Jazz Pharmaceuticals INC. | $122.24 | 2019 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $100.00 | 2019 | |
| Eisai INC. | $90.29 | 2019 | |
| Davol INC. | $64.28 | 2024-2025 | Arista, Phasix Mesh |
| Tela Bio, INC. | $55.92 | 2022-2023 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) |
| Abbvie INC. | $55.22 | 2023-2024 | Linzess, Creon, Viberzi |
| Kerecis Limited | $53.88 | 2022-2025 | Kerecis Surgiclose, Kerecis Omega3 Marigen, Kerecis Omega3 Graftguide |
Show all 30 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Teleflex LLC | $34.32 | 2024 | Deknatel |
| Ethicon US, LLC | $33.45 | 2025 | Echelon; Endopath |
| Medtronic, INC. | $32.93 | 2022-2024 | Ligasure |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $29.14 | 2020 | |
| Madrigal Pharmaceuticals | $27.99 | 2025 | Rezdiffra |
| Nalpropion Pharmaceuticals LLC | $24.99 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $21.48 | 2023 | Jardiance |
| Integra Lifesciences Corporation | $20.68 | 2022 | |
| Polarityte, INC. | $16.94 | 2019 | |
| Aimmune Therapeutics, INC. | $16.72 | 2024 | |
| Pfizer INC. | $15.88 | 2025 | |
| Biohaven Pharmaceuticals, INC. | $15.07 | 2021 | |
| Convatec INC. | $14.89 | 2022 | |
| Abbott Laboratories | $14.43 | 2024 | Freestyle Libre 3 |
| Pacira Pharmaceuticals Incorporated | $13.54 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Simpson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.